SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000078003-20-000038
Filing Date
2020-06-04
Accepted
2020-06-04 16:25:17
Documents
1
Period of Report
2020-06-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5822
  Complete submission text file 0000078003-20-000038.txt   8553
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Reporting) CIK: 0000078003 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38890 | Film No.: 20943236
SIC: 2834 Pharmaceutical Preparations

Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Issuer) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 235 EAST 42ND STREET NEW YORK NY 10017
Business Address 235 EAST 42ND STREET NEW YORK NY 10017 2127332323
Pfizer Ventures (US) LLC (Reporting) CIK: 0001776087 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38890 | Film No.: 20943234

Mailing Address 235 EAST 42ND STREET NEW YORK NY 10017
Business Address 235 EAST 42ND STREET NEW YORK NY 10017 9089011641
Pfizer Strategic Investment Holdings LLC (Reporting) CIK: 0001776115 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38890 | Film No.: 20943235